Key findings include: Mean weight loss of 24.2% (approximately 58 pounds or 26.2 kg) with 12 mg weekly dose after 48 weeks Dose-dependent efficacy across 1 mg, 4 mg, 8 mg, and 12 mg dose groups At 48 weeks, 100% of participants receiving 8 mg or 12 mg achieved at least 5% weight loss 93% of participants on 12 mg achieved 15% or more weight loss , far exceeding current therapeutic benchmarks Greater weight reduction observed in participants with BMI greater than or equal to 35 compared to those with BMI below 35 The magnitude of weight loss approaches that typically observed only with bariatric-metabolic surgery, representing a potential paradigm shift in pharmacological obesity treatment[11]
Curtis L, Humayun MA, Walker J, Hampton K, Partridge H
It could also cause adverse effects
Another key point we will cover is the timing of your flu shot if youre on semaglutide
Plans with obesity GLP-1 coverage had just 5.5% more GLP-1 days per enrollee than plans without it in January 2021
Push Health customer support is rated mid-range, with response times to platform-level inquiries running several days in many reviews